Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trimethoprim | 2 | 2021 | 15 | 1.320 |
Why?
|
| Sulfadiazine | 2 | 2021 | 23 | 0.820 |
Why?
|
| Animal Care Committees | 2 | 2012 | 5 | 0.700 |
Why?
|
| Hematology | 1 | 2021 | 31 | 0.660 |
Why?
|
| Housing, Animal | 4 | 2020 | 51 | 0.600 |
Why?
|
| Choroidal Neovascularization | 3 | 2023 | 23 | 0.570 |
Why?
|
| Mice | 23 | 2023 | 12269 | 0.560 |
Why?
|
| Gastrointestinal Microbiome | 6 | 2022 | 590 | 0.530 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 291 | 0.510 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 836 | 0.470 |
Why?
|
| Microbiota | 7 | 2022 | 425 | 0.400 |
Why?
|
| Animals | 30 | 2023 | 28155 | 0.390 |
Why?
|
| Animal Experimentation | 1 | 2012 | 9 | 0.380 |
Why?
|
| Wet Macular Degeneration | 2 | 2023 | 22 | 0.370 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 163 | 0.350 |
Why?
|
| Animal Welfare | 2 | 2020 | 59 | 0.330 |
Why?
|
| Mice, Inbred ICR | 2 | 2021 | 75 | 0.330 |
Why?
|
| Animal Husbandry | 2 | 2020 | 33 | 0.310 |
Why?
|
| Research Support as Topic | 1 | 2010 | 89 | 0.300 |
Why?
|
| Neointima | 2 | 2020 | 14 | 0.300 |
Why?
|
| Carotid Artery Injuries | 2 | 2020 | 21 | 0.300 |
Why?
|
| Graft Rejection | 3 | 2022 | 1120 | 0.300 |
Why?
|
| Administration, Oral | 2 | 2021 | 657 | 0.290 |
Why?
|
| Skin Transplantation | 3 | 2022 | 191 | 0.290 |
Why?
|
| Research Design | 1 | 2012 | 617 | 0.290 |
Why?
|
| Medetomidine | 1 | 2008 | 1 | 0.280 |
Why?
|
| Cebus | 1 | 2008 | 19 | 0.270 |
Why?
|
| Ketamine | 1 | 2008 | 26 | 0.270 |
Why?
|
| Anesthesia | 1 | 2008 | 175 | 0.230 |
Why?
|
| Biomedical Research | 1 | 2010 | 438 | 0.230 |
Why?
|
| Skin | 2 | 2019 | 578 | 0.220 |
Why?
|
| Rodentia | 2 | 2022 | 47 | 0.200 |
Why?
|
| Corticosterone | 1 | 2023 | 35 | 0.200 |
Why?
|
| Vibration | 1 | 2023 | 29 | 0.200 |
Why?
|
| Organ Transplantation | 3 | 2022 | 295 | 0.200 |
Why?
|
| Gastrointestinal Tract | 2 | 2015 | 195 | 0.190 |
Why?
|
| Pest Control | 1 | 2023 | 6 | 0.190 |
Why?
|
| Dust | 2 | 2020 | 26 | 0.190 |
Why?
|
| Bacteria | 2 | 2018 | 509 | 0.190 |
Why?
|
| Risk Assessment | 1 | 2010 | 2440 | 0.190 |
Why?
|
| Mite Infestations | 1 | 2022 | 6 | 0.180 |
Why?
|
| Pyrethrins | 1 | 2022 | 10 | 0.180 |
Why?
|
| Mites | 1 | 2022 | 17 | 0.180 |
Why?
|
| Macular Degeneration | 1 | 2022 | 50 | 0.180 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2020 | 80 | 0.180 |
Why?
|
| Dermatitis | 1 | 2022 | 34 | 0.180 |
Why?
|
| Rectal Prolapse | 1 | 2021 | 10 | 0.180 |
Why?
|
| Retinal Diseases | 1 | 2022 | 84 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 8 | 2022 | 3435 | 0.170 |
Why?
|
| Immunocompetence | 1 | 2020 | 24 | 0.160 |
Why?
|
| Floors and Floorcoverings | 1 | 2020 | 7 | 0.160 |
Why?
|
| Arterivirus Infections | 1 | 2020 | 4 | 0.160 |
Why?
|
| Weight Gain | 1 | 2021 | 128 | 0.160 |
Why?
|
| Lactate dehydrogenase-elevating virus | 1 | 2020 | 6 | 0.160 |
Why?
|
| Animals, Laboratory | 1 | 2020 | 25 | 0.160 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 285 | 0.160 |
Why?
|
| Drug Combinations | 1 | 2020 | 200 | 0.160 |
Why?
|
| Environmental Microbiology | 1 | 2020 | 22 | 0.160 |
Why?
|
| Bedding and Linens | 1 | 2019 | 16 | 0.150 |
Why?
|
| Rodent Diseases | 1 | 2019 | 35 | 0.150 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 2495 | 0.150 |
Why?
|
| Diet, High-Fat | 2 | 2022 | 135 | 0.150 |
Why?
|
| Arteritis | 1 | 2018 | 9 | 0.150 |
Why?
|
| Carotid Arteries | 1 | 2020 | 131 | 0.150 |
Why?
|
| Germ-Free Life | 4 | 2021 | 83 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1999 | 201 | 0.140 |
Why?
|
| Diet | 1 | 2021 | 460 | 0.130 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2017 | 46 | 0.120 |
Why?
|
| Constipation | 1 | 2017 | 66 | 0.120 |
Why?
|
| Mucin-2 | 1 | 2015 | 12 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 240 | 0.110 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2023 | 259 | 0.110 |
Why?
|
| Interleukin-10 | 1 | 2015 | 163 | 0.110 |
Why?
|
| Immunization | 1 | 2014 | 154 | 0.100 |
Why?
|
| Circadian Clocks | 1 | 2015 | 66 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 589 | 0.100 |
Why?
|
| Dysbiosis | 1 | 2015 | 91 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2715 | 0.100 |
Why?
|
| Retroviridae Infections | 1 | 2014 | 43 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 214 | 0.100 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 74 | 0.100 |
Why?
|
| Dexamethasone | 1 | 2015 | 312 | 0.100 |
Why?
|
| Allergens | 1 | 2014 | 189 | 0.100 |
Why?
|
| Omentum | 1 | 2013 | 68 | 0.100 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 79 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 162 | 0.090 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2022 | 10 | 0.090 |
Why?
|
| Choroid | 2 | 2022 | 22 | 0.090 |
Why?
|
| Peritoneal Neoplasms | 1 | 2013 | 184 | 0.090 |
Why?
|
| Visual Acuity | 2 | 2023 | 209 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2013 | 270 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2023 | 398 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2023 | 291 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2010 | 26 | 0.080 |
Why?
|
| Organizational Policy | 1 | 2010 | 57 | 0.080 |
Why?
|
| Hyperplasia | 2 | 2020 | 147 | 0.070 |
Why?
|
| Inflammation | 1 | 2015 | 1050 | 0.070 |
Why?
|
| Male | 9 | 2023 | 44553 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 646 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2010 | 236 | 0.070 |
Why?
|
| Restraint, Physical | 1 | 2008 | 31 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 492 | 0.070 |
Why?
|
| Antigen-Presenting Cells | 2 | 2019 | 145 | 0.060 |
Why?
|
| Transplantation, Homologous | 2 | 2022 | 1014 | 0.060 |
Why?
|
| Imidazoles | 1 | 2008 | 138 | 0.060 |
Why?
|
| Female | 6 | 2023 | 48698 | 0.060 |
Why?
|
| Mastication | 1 | 2008 | 78 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 797 | 0.060 |
Why?
|
| Transcriptome | 2 | 2022 | 762 | 0.060 |
Why?
|
| DNA, Bacterial | 2 | 2018 | 232 | 0.060 |
Why?
|
| Biomechanical Phenomena | 1 | 2008 | 489 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2020 | 894 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 367 | 0.050 |
Why?
|
| Nesting Behavior | 1 | 2023 | 20 | 0.050 |
Why?
|
| Noise | 1 | 2023 | 28 | 0.050 |
Why?
|
| Darkness | 1 | 2022 | 47 | 0.050 |
Why?
|
| Insecta | 1 | 2023 | 55 | 0.050 |
Why?
|
| Body Temperature Regulation | 1 | 2022 | 59 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2019 | 2121 | 0.050 |
Why?
|
| Permethrin | 1 | 2022 | 9 | 0.050 |
Why?
|
| Delayed-Action Preparations | 1 | 2022 | 116 | 0.040 |
Why?
|
| Retina | 1 | 2023 | 215 | 0.040 |
Why?
|
| Photoperiod | 1 | 2022 | 73 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2022 | 74 | 0.040 |
Why?
|
| Lidocaine | 1 | 2021 | 62 | 0.040 |
Why?
|
| Lasers | 1 | 2021 | 101 | 0.040 |
Why?
|
| Light | 1 | 2022 | 288 | 0.040 |
Why?
|
| Immunity | 1 | 2022 | 153 | 0.040 |
Why?
|
| T-Lymphocytes | 2 | 2019 | 1275 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 2755 | 0.040 |
Why?
|
| Rectum | 1 | 2021 | 149 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 259 | 0.040 |
Why?
|
| Pasteurellaceae | 1 | 2019 | 5 | 0.040 |
Why?
|
| Helicobacter | 1 | 2019 | 5 | 0.040 |
Why?
|
| Laboratory Animal Science | 1 | 2019 | 8 | 0.040 |
Why?
|
| Caliciviridae Infections | 1 | 2019 | 10 | 0.040 |
Why?
|
| Sentinel Surveillance | 1 | 2019 | 23 | 0.040 |
Why?
|
| Norovirus | 1 | 2019 | 13 | 0.040 |
Why?
|
| Sample Size | 1 | 2020 | 128 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2023 | 390 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 116 | 0.040 |
Why?
|
| Streptozocin | 1 | 1999 | 56 | 0.040 |
Why?
|
| Staphylococcus epidermidis | 1 | 2019 | 16 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 1999 | 111 | 0.040 |
Why?
|
| Femoral Vein | 1 | 1999 | 42 | 0.040 |
Why?
|
| Vascular Patency | 1 | 1999 | 118 | 0.040 |
Why?
|
| C-Peptide | 1 | 1999 | 184 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 1999 | 232 | 0.040 |
Why?
|
| Insulin Infusion Systems | 1 | 1999 | 44 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 414 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2018 | 55 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 66 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 1028 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2019 | 179 | 0.030 |
Why?
|
| Catheterization | 1 | 1999 | 218 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 179 | 0.030 |
Why?
|
| Pancreas | 1 | 1999 | 258 | 0.030 |
Why?
|
| Loperamide | 1 | 2017 | 7 | 0.030 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 1999 | 247 | 0.030 |
Why?
|
| Chronic Disease | 1 | 1999 | 960 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2016 | 171 | 0.030 |
Why?
|
| Humans | 6 | 2022 | 93511 | 0.030 |
Why?
|
| Allografts | 1 | 2016 | 205 | 0.030 |
Why?
|
| Leukocytes | 1 | 2016 | 210 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2015 | 146 | 0.030 |
Why?
|
| Clostridium | 1 | 2014 | 24 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 2014 | 40 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 1999 | 990 | 0.030 |
Why?
|
| Kidney | 1 | 1999 | 1111 | 0.030 |
Why?
|
| Insulin | 1 | 1999 | 1185 | 0.030 |
Why?
|
| Freund's Adjuvant | 1 | 2014 | 25 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2014 | 84 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2014 | 102 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 133 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 1101 | 0.030 |
Why?
|
| Body Weight | 1 | 2015 | 449 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 280 | 0.030 |
Why?
|
| Azure Stains | 1 | 2013 | 6 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2013 | 65 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1741 | 0.020 |
Why?
|
| Feces | 1 | 2015 | 360 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 522 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 80 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 353 | 0.020 |
Why?
|
| Graft Survival | 1 | 2016 | 937 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 784 | 0.020 |
Why?
|
| Species Specificity | 1 | 2014 | 684 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1999 | 3829 | 0.020 |
Why?
|
| Colon | 1 | 2015 | 540 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 893 | 0.020 |
Why?
|
| Intestines | 1 | 2014 | 432 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 2910 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2014 | 463 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 700 | 0.020 |
Why?
|
| Liver | 1 | 2015 | 1210 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1518 | 0.020 |
Why?
|
| Obesity | 1 | 2015 | 1018 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1985 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 9098 | 0.010 |
Why?
|